Literature DB >> 2021146

Death certificate reporting of confirmed airways obstructive disease.

A E Camilli1, D R Robbins, M D Lebowitz.   

Abstract

Death certificate reporting of chronic airways disease was examined during 13 years of follow-up in the Tucson Epidemiologic Study of Airways Obstructive Disease. The Tucson study population is a geographically clustered stratified random sample of white, non-Mexican-American households in Tucson, Arizona. The initial survey was performed in 1972-1973. Using clinical and physiologic criteria from nine surveys to define airways obstructive disease in the population, the authors compared death certificate reporting with these criteria as the underlying cause and as reported anywhere on the death certificate. Reporting was related to the degree of antemortem airways obstruction. Sex differences in reporting were also noted. Females showed greater rates of reporting at low levels of impairment while males showed greater reporting at high levels of impairment. When airways obstructive disease was not the underlying cause of death, the type of underlying cause was found to affect reporting of airways obstructive disease on the death certificate.

Entities:  

Mesh:

Year:  1991        PMID: 2021146     DOI: 10.1093/oxfordjournals.aje.a115958

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

1.  Long-term ambient multipollutant exposures and mortality.

Authors:  Jaime E Hart; Eric Garshick; Douglas W Dockery; Thomas J Smith; Louise Ryan; Francine Laden
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

2.  T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.

Authors:  C Lambers; S Hacker; M Posch; K Hoetzenecker; A Pollreisz; M Lichtenauer; W Klepetko; H Jan Ankersmit
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

3.  Dyspnea reproducibility in a rural Bangladesh population.

Authors:  Gene Raymond Pesola; Faruque Parvez; Sultana Jasmin; Abul Kalam Mohammad Rabiul Hasan; Habibul Ahsan
Journal:  Clin Respir J       Date:  2009-10       Impact factor: 2.570

4.  Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol.

Authors:  K Katsouyanni; J Schwartz; C Spix; G Touloumi; D Zmirou; A Zanobetti; B Wojtyniak; J M Vonk; A Tobias; A Pönkä; S Medina; L Bachárová; H R Anderson
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

5.  Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.

Authors:  C Fuhrman; E Jougla; J Nicolau; D Eilstein; M-C Delmas
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

6.  Chronic obstructive pulmonary disease after myocardial infarction in the community.

Authors:  Francesca Bursi; Robert Vassallo; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

7.  Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III.

Authors:  A C Looker
Journal:  Osteoporos Int       Date:  2014-01-17       Impact factor: 4.507

Review 8.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.

Authors:  D M Mannino; A S Buist; T L Petty; P L Enright; S C Redd
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 10.  Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.

Authors:  Carlos Zamarrón; Vanesa García Paz; Emilio Morete; Felix del Campo Matías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.